InsidersTradesSigma
Across 34 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by 정종선, Executive. Officer active across 2 companies, notably 신테카바이오. Cumulatively, 75 disclosures have been published. Regulator: DART (FSS). All data is openly available.
25 of 75 declarations
Jeong Jong-seon is an executive at Shintech Bio, a company specializing in the biopharmaceutical sector. He plays a key role in the strategic direction of the company, contributing to its development and growth in the market. His expertise and vision are essential for navigating a constantly evolving business environment.